Skip to content
Search

Latest Stories

Role of Pharmacists in Managing Erectile Dysfunction

Role of Pharmacists in Managing Erectile Dysfunction

This article explores the treatment options for erectile dysfunction and the pivotal role that pharmacists play in its management

Erectile dysfunction (ED), also known as impotence, is characterized by the consistent or recurrent inability to achieve and/or maintain an erection sufficient for sexual intercourse. It becomes increasingly common with age, affecting approximately 50 – 55 per cent of men aged between 40 and 70 years.

ED is estimated to affect up to three-quarters of men globally, and by 2025, 322 million men are expected to experience it.


Research indicates that erectile dysfunction is highly prevalent in the UK, affecting over a quarter of younger men. Among Brits with ED, cardiometabolic and psychological conditions were frequently observed.

Despite the high prevalence of erectile dysfunction among men, it remains poorly understood, underdiagnosed, and undertreated.

Causes

Impotence can arise from various factors, such as physical or psychological issues, and can manifest either gradually or suddenly.

Erectile dysfunction is often associated with obesity, high blood pressure, high cholesterol and diabetes, all of which pose significant health risks. Therefore, seeking medical advice is crucial.

As per the British Association of Urological Surgeons Limited (BAUS), 90 per cent of men experiencing erectile dysfunction have at least one underlying physical cause for their problem. The primary abnormalities identified are - cardiovascular disease in 40 per cent and diabetes in 33 per cent.

Other associated physical factors include hormone imbalance (high prolactin or low testosterone levels), side effects of certain medications (antihypertensives, antipsychotics, antidepressants, antihistamines, heroin, cocaine, methadone), neurological disorders (multiple sclerosis or Parkinson’s disease), pelvic surgery or trauma, and anatomical abnormalities (tight foreskin, short penile frenulum, Peyronie's disease which causes scar tissue and curvature in the penis).

Psychological causes may encompass anxiety, stress, depression, and relationship issues. According to BAUS, a psychological component, commonly referred to as "performance anxiety", is prevalent in men with impotence.

Treatment

If the cause is psychological, the patient and his partner may benefit from counselling. Typically, physical causes are treated by directly addressing the underlying condition. In some cases, lifestyle changes—such as adopting a healthy diet, reducing alcohol consumption, quitting smoking, losing weight, and increasing physical activity—can significantly improve erectile dysfunction.

If no treatable cause is identified, first-line treatment often involves the use of phosphodiesterase inhibitors such as sildenafil (Viagra, Eropid), tadalafil (Cialis), vardenafil (Levitra) or avanafil (Spedra). These medications are recommended to temporarily enhance blood flow to the penis. However, the type and dosage of the medication will depend on the patient's situation.

Sildenafil and tadalafil are available both over the counter (OTC) and through prescription in the UK.

If the medication proves ineffective, causes significant side effects, or cannot be used, other treatment options may be indicated. These include penile injections, the medicated urethral system for erection (MUSE), vacuum erection devices (VEDs), vascular surgery or angioplasty, and penile prostheses.

However, a multidisciplinary approach that combines medical treatment with psychological therapy is preferred over a single-mode treatment. Increasing evidence suggests that psychological interventions for ED can enhance the effectiveness of medical treatments, and improve patient's adherence to treatment and the quality of the sexual relationship.

The dangers of buying ED medications online

Patients can obtain branded versions of sildenafil, such as Viagra and Eropid, through a private prescription from their doctor, at a pharmacy via a discussion with the pharmacist, or purchase online.

Even though ED medications are accessible for purchase without a prescription from pharmacies, men are still opting for cheap versions found online, risking their health.

According to the Medicines and Healthcare products Regulatory Agency (MHRA), erectile dysfunction medicines are a popular target for criminals selling unlicensed and counterfeit medicines.

The MHRA and UK Border Force seize millions of pounds worth of unlicensed and counterfeit ED medicines every year.

When dispensing sildenafil, pharmacists are encouraged to inquire about patients' overall health to ensure the pill is safe for them to take, and to educate them about potential side effects. If there are any safety concerns, the NHS advises pharmacists to recommend that the patient consult a doctor.

The NHS cautions people to be careful when purchasing sildenafil online, as “many websites sell fake medicines.”

“Online medicines are not always regulated and the ingredients in them can vary from one pack to another. They can cause unpleasant side effects or may not be suitable for you,” the NHS website reads.

If you choose to buy sildenafil online, the health service advises ensuring that the online pharmacy is registered with the General Pharmaceutical Council (GPhC), the online doctor service is registered with the Care Quality Commission (CQC), and all doctors are registered with the General Medical Council (GMC).

Consult a pharmacist for OTC treatment: PAGB

Michelle Riddalls, CEO of PAGB, noted that the availability of over-the-counter erectile dysfunction medications has transformed the ability of men to take control of their sexual health and manage self-treatable conditions. However, he also acknowledged that ED medicines have become a popular target for criminals selling unlicensed and counterfeit medicines.

“Erectile dysfunction can be a debilitating condition and ensuring men feel they have choice and fast access to safe treatment is important.

“Unfortunately, erectile dysfunction medicines have been a popular target for criminals selling unlicensed and counterfeit medicines,” she told Pharmacy Business.

When asked if the PAGB has taken any actions to prevent the sale of fraudulent OTC medicines, Riddalls said: “Our members have not raised any concerns about reports of an increase in the sale of unlicensed or counterfeit erectile dysfunction medicines.”

Meanwhile, they urge individuals seeking OTC treatment for erectile dysfunction to speak to a pharmacist who can provide advice and support about products.

People are also advised to ensure that any online purchase is made from a reputable source, such as a licensed brand or pharmacy company’s website.

How pharmacists help in ED management

Alwyn Fortune, RPS Policy and Engagement Lead for Wales and a community pharmacist, stated that pharmacists are well positioned to provide advice on the treatment of erectile dysfunction.

He highlighted that pharmacists can offer confidential, private consultations and assist in addressing any concerns patients may have.

“Using standardised checklists, pharmacists identify suitable treatments and can detect signs of underlying health conditions. If there are concerns or if medicines may not be suitable, pharmacists can refer patients to other practitioners.

“Pharmacists also support broader public health messaging, like conducting blood pressure checks and providing smoking cessation advice, which can address some underlying issues contributing to erectile dysfunction," he told Pharmacy Business.

With many effective options now available without the need for a prescription, pharmacists play a crucial role in helping patients ensure they receive appropriate treatment, he added.

 

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less